Viewing Study NCT04379518


Ignite Creation Date: 2025-12-25 @ 4:42 AM
Ignite Modification Date: 2026-01-16 @ 2:42 AM
Study NCT ID: NCT04379518
Status: SUSPENDED
Last Update Posted: 2023-03-06
First Post: 2020-05-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients
Sponsor: Roswell Park Cancer Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hematopoietic and Lymphoid Cell Neoplasm View
None Malignant Solid Neoplasm View
None Symptomatic COVID-19 Infection Laboratory-Confirmed View
Keywords: